DHR vs HON: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Honeywell International Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
Honeywell International Inc. · Industrials
$229.01
-14.5% upside to fair value
Grade D
QuantHub Verdict
DHR has more upside to fair value
(+8.9%).
HON trades at a lower forward P/E
(32.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
HON |
| Current Price |
$177.17 |
$229.01 |
| Fair Value Estimate |
$192.90 |
$195.88 |
| Upside to Fair Value |
+8.9%
|
-14.5%
|
| Market Cap |
$125.4B |
$145.1B |
| Forward P/E |
34.1x
|
32.4x
|
| EV / EBITDA |
20.8x
|
23.4x
|
| Price / Sales |
5.1x
|
4.0x
|
| Price / FCF |
23.7x
|
35.3x
|
| Revenue Growth YoY |
+3.7%
|
-6.9%
|
| Gross Margin |
60.7%
|
36.9%
|
| Operating Margin |
21.0%
|
14.9%
|
| Return on Equity |
7.1%
|
23.6%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
2.83%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Honeywell International Inc. operates as a diversified industrial conglomerate with leading market positions in aerospace, building automation, industrial automation, and energy solutions. The company benefits from a durable competitive moat with 20-40%+ market share in key niches such as avionics and aerospace systems. Despite strong free cash flow generation and a consistent dividend supported …
Accumulation Zones
| Metric |
DHR |
HON |
| Zone Low |
$144.68 |
$146.91 |
| Zone High |
$163.97 |
$166.50 |
| In Buy Zone? |
No
|
No
|